نتایج جستجو برای: t cell vaccination

تعداد نتایج: 2220123  

Journal: :The Journal of Experimental Medicine 2005
Heather L. Van Epps

Vaccination with tumor antigens causes tumor regression in some melanoma patients despite negligible expansion of vaccine-specific T cells. Vaccination may instead result in the expansion of T cells specific for tumor antigens not contained in the vaccine, thus facilitating tumor regression, according to two articles from Pierre Coulie and colleagues on pages 241 and 249. Tumor-specific T cells...

Journal: :Journal of immunology 2011
Peter Johannes Holst Jan Pravsgaard Christensen Allan Randrup Thomsen

The impact of prophylactic vaccination against acute and chronic infection in a Th-deficient host has not been adequately addressed because of difficulties in generating protective immunity in the absence of CD4(+) T cell help. In this study, we demonstrated that a broad CD8(+) T cell immune response could be elicited in MHC class II-deficient mice by vaccination with adenovirus encoding lympho...

2015
Carmen Elena Gómez Beatriz Perdiguero Juan García-Arriaza Victoria Cepeda Carlos Óscar Sánchez-Sorzano Beatriz Mothe José Luis Jiménez María Ángeles Muñoz-Fernández Jose M. Gatell Juan Carlos López Bernaldo de Quirós Christian Brander Felipe García Mariano Esteban Alan Landay

TRIAL DESIGN Previous studies suggested that poxvirus-based vaccines might be instrumental in the therapeutic HIV field. A phase I clinical trial was conducted in HIV-1-infected patients on highly active antiretroviral therapy (HAART), with CD4 T cell counts above 450 cells/mm3 and undetectable viremia. Thirty participants were randomized (2:1) to receive either 3 intramuscular injections of MV...

2015
Adam Penn-Nicholson Hennie Geldenhuys Wivine Burny Robbert van der Most Cheryl L. Day Erik Jongert Philippe Moris Mark Hatherill Opokua Ofori-Anyinam Willem Hanekom

BACKGROUND Vaccination that prevents tuberculosis (TB) disease, particularly in adolescents, would have the greatest impact on the global TB epidemic. Safety, reactogenicity and immunogenicity of the vaccine candidate M72/AS01E was evaluated in healthy, HIV-negative adolescents in a TB endemic region, regardless of Mycobacterium tuberculosis (M.tb) infection status. METHODS In a phase II, dou...

2013
Rodrigo Hess Michelini Teresa Manzo Tabea Sturmheit Veronica Basso Martina Rocchi Massimo Freschi Joanna Listopad Thomas Blankenstein Matteo Bellone Anna Mondino

Vaccination can synergize with transplantation of allogeneic hematopoietic stem cells to cure hematologic malignancies, but the basis for this synergy is not understood to the degree where such approaches could be effective for treating solid tumors. We investigated this issue in a transgenic mouse model of prostate cancer treated by transplantation of a nonmyeloablative MHC-matched, single Y c...

2017
Bin Li Hanmei Yuan Li Chen Heqiang Sun Jian Hu Shanshan Wei Zhuo Zhao Quanming Zou Chao Wu

Adjuvants are widely used to enhance the effects of vaccines against pathogen infections. Interestingly, different adjuvants and vaccination routes usually induce dissimilar immune responses, and can even have completely opposite effects. The mechanism remains unclear. In this study, urease B subunit (UreB), an antigen of Helicobacter pylori (H. pylori) that can induce protective immune respons...

2015
Shiwen Peng Joshua W. Wang Balasubramanyam Karanam Chenguang Wang Warner K. Huh Ronald D. Alvarez Sara I. Pai Chien-fu Hung T. -C. Wu Richard B. S. Roden

Clinical studies suggest that responses to HPV16 E6E7L2 fusion protein (TA-CIN) vaccination alone are modest, and GPI-0100 is a well-tolerated, potent adjuvant. Here we sought to optimize both the immunogenicity of TA-CIN via formulation with GPI-0100 and treatment of HPV16+ cancer by vaccination after cisplatin chemotherapy. HPV16 neutralizing serum antibody titers, CD4+ T cell proliferative a...

Journal: :Cancer research 2006
Petra Baumgaertner Nathalie Rufer Estelle Devevre Laurent Derre Donata Rimoldi Christine Geldhof Verena Voelter Danielle Liénard Pedro Romero Daniel E Speiser

Clinical trials have shown that strong tumor antigen-specific CD8 T-cell responses are difficult to induce but can be achieved for T-cells specific for melanoma differentiation antigens, upon repetitive vaccination with stable emulsions prepared with synthetic peptides and incomplete Freund's adjuvant. Here, we show in four melanoma patients that ex vivo detectable T-cells and thus strong T-cel...

Journal: :The Journal of clinical investigation 2014
Enoch Muyanja Aloysius Ssemaganda Pearline Ngauv Rafael Cubas Helene Perrin Divya Srinivasan Glenda Canderan Benton Lawson Jakub Kopycinski Amanda S Graham Dawne K Rowe Michaela J Smith Sharon Isern Scott Michael Guido Silvestri Thomas H Vanderford Erika Castro Giuseppe Pantaleo Joel Singer Jill Gillmour Noah Kiwanuka Annet Nanvubya Claudia Schmidt Josephine Birungi Josephine Cox Elias K Haddad Pontiano Kaleebu Patricia Fast Rafick-Pierre Sekaly Lydie Trautmann Denis Gaucher

BACKGROUND Defining the parameters that modulate vaccine responses in African populations will be imperative to design effective vaccines for protection against HIV, malaria, tuberculosis, and dengue virus infections. This study aimed to evaluate the contribution of the patient-specific immune microenvironment to the response to the licensed yellow fever vaccine 17D (YF-17D) in an African cohor...

1999
Andreas A. O. Eggert Marco W. J. Schreurs Otto C. Boerman Wim J. C. Oyen Annemiek J. de Boer Cornelis J. A. Punt Carl G. Figdor Gosse J. Adema

Dendritic cells (DCs) are professional antigen-presenting cells, well equipped to initiate an immune response. Currently, tumor antigenderived peptide loaded DCs are used in clinical vaccination in cancer patients. However, the optimal dose and route of administration of a DC vaccine still remain to be determined. Using indium-111-labeled DCs, we investigated whether the route of administration...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید